Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The New England Journal of Medicine, 384 (11), 9891002
10.2174/1570162X11311030007 47
Paired and independent-sample t tests were used for comparing the baseline data, comparison of data at baseline and post-fasting, and the changes in variables between groups
Activated HIF1 of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer
The phase 2 study to evaluate the efficacy, safety and tolerability of maridebart cafraglutide is currently ongoing (ClinicalTrials.gov number, NCT05669599)
US$ 25.04
US$ 28.50
US$ 20.98
US$ 21.58
